Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Observational 1

Sponsor

Cancer Type

CNS 2Sarcoma 1Genitourinary 1Gastrointestinal 1

Conditions

Colorectal Neoplasms 2Colonic Neoplasms 2Sarcoma 1Rectal Neoplasms 1Pleuropulmonary blastoma 1Neuroblastoma 1Medulloblastoma 1Liver Neoplasms 1Kidney Neoplasms 1Hepatoblastoma 1Central Nervous System Neoplasms 1

Interventions

Specimen Handling 6X-Rays 5Phantoms, Imaging 5Magnetic Resonance Spectroscopy 5Carboplatin 5Paclitaxel 4Nuclear Medicine Department, Hospital 4Biopsy 4selpercatinib 3Thiotepa 3Melphalan 3Ifosfamide 3Granulocyte Colony-Stimulating Factor 3Filgrastim 3Etoposide 3Busulfan 3tazemetostat 2sargramostim 2olaparib 2larotrectinib 2etoposide phosphate 2erdafitinib 2ensartinib 2Vemurafenib 2Temozolomide 2Radiotherapy 2Peripheral Blood Stem Cell Transplantation 2Nivolumab 2Mesna 2LY3023414 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Central Nervous System Neoplasms × Cytogenetic Analysis × Gastrointestinal × Clear all
NCT01353300 2016-07-11

Gene Mutation in Samples From Young Patients With Pleuropulmonary Blastoma Syndrome at Risk for Developing Cancer

Children's Oncology Group

Completed
31 enrolled
CNSGastrointestinalGenitourinarySarcoma

Pleuropulmonary blastoma, Kidney Neoplasms, Liver Neoplasms, Medulloblastoma, Neuroblastoma, Sarcoma, Central Nervous System Neoplasms, Hepatoblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡